Jun 06, 2023 / 09:40PM GMT
Andrew Frederick Brackmann - William Blair & Company L.L.C., Research Division - Research Analyst
Hi, everyone. Good afternoon. Congratulations on making it to the last session of today. For those of you who don't know me, my name is Andrew Brackmann, I cover Diagnostics for the equity research team at William Blair. This afternoon, we have the team from Guardant Health joining us. We have co-founders and co-CEOs, Helmy Eltoukhy and AmirAli Talasaz; CFO, Mike Bell. And in the crowd, we've got Alex Kleban from Investor Relations. In terms of housekeeping, I am required to tell you that for a full list of research disclosures and potential conflicts of interest, please see williamblair.com. And in terms of a breakout session, given this is the last one of the day, we'll just stick in here after the formal presentation's over. So with that, I'll turn it over to the team. Thanks.
Helmy Eltoukhy - Guardant Health, Inc. - Co-Founder, Co-CEO & Chairman
Thanks, Andrew, for the great introduction. And so let's get into it. Please note our forward-looking statement
Guardant Health Inc at William Blair Growth Stock Conference Transcript
Jun 07, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers